North Carolina Ozempic, Mounjaro, Wegovy and Other GLP-1 Drug Lawsuit Attorneys

Experienced Lawyers Handling Weight Loss & Diabetes Drug Claims in North Carolina

Our North Carolina weight loss and diabetes drug lawyers can help you get maximum compensation. Riddle & Riddle Injury Lawyers.

If you or a loved one in North Carolina have experienced serious health issues after using Ozempic, Mounjaro, Wegovy, Rybelsus, Saxenda, Trulicity, or other GLP-1 receptor agonist medications, you may be entitled to significant financial compensation in a North Carolina weight loss lawsuit or diabetes drug lawsuit. Health conditions that may qualify include gastroparesis (stomach paralysis), gastroenteritis, pancreatic cancer, pancreatic cancer, and non-arteritic anterior ischemic optic neuropathy (NAION)

At Riddle & Riddle injury lawyers, we are committed to protecting the rights of North Carolinians harmed by potentially dangerous pharmaceutical drugs. Our experienced dangerous drug attorneys are ready to help however we can.

For a free case review with an experienced North Carolina weight loss drug and diabetes drug lawsuit attorney, please contact our team or call 1-800-525-7111. North Carolina is our home and we’re proud to fight for justice for our neighbors.

We are committed to seeking maximum compensation for our clients.

GLP-1 receptor agonists are a class of medications primarily prescribed to manage type 2 diabetes by regulating blood sugar levels. Due to their appetite-suppressing properties, some have also been approved or used off-label for weight loss. Notable medications in this class include:

  • Semaglutide:
    • Ozempic: Approved for type 2 diabetes management.
    • Wegovy: Approved for chronic weight management.
    • Rybelsus: Oral formulation for type 2 diabetes.
  • Tirzepatide:
    • Mounjaro: Approved for type 2 diabetes; also used for weight loss.
  • Liraglutide:
    • Victoza: Approved for type 2 diabetes.
    • Saxenda: Approved for weight management.
  • Dulaglutide:
    • Trulicity: Approved for type 2 diabetes.
  • Exenatide:
    • Byetta: Approved for type 2 diabetes.
    • Bydureon BCise: Extended-release formulation.

While these drugs have been effective for many, concerns have arisen regarding their potential side effects. Reported adverse reactions include:

  • Gastrointestinal Issues:
    • Nausea
    • Vomiting
    • Diarrhea
    • Constipation
    • Abdominal pain
    • Gastroparesis (delayed stomach emptying)
  • Vision Problems:
    • Blurred vision
    • Vision loss
  • Kidney and Gallbladder Issues:
    • Acute kidney injury
    • Gallbladder disease
  • Pancreatitis (inflammation of the pancreas)
Free Case Review - We Don't Get Paid Unless You Do

These side effects have led to numerous lawsuits against manufacturers, alleging that they failed to adequately warn patients about the potential risks associated with these medications. Notably, as of February 2024, lawsuits involving Ozempic, Wegovy, Mounjaro, and similar drugs have been consolidated into a multidistrict litigation (MDL) to streamline the legal process.

Manufacturers have strongly denied any liability and/or wrongdoing in these cases.

July 2025 Updates

Litigation involving popular GLP-1 receptor agonist drugs—including Ozempic, Wegovy, Mounjaro, and Rybelsus—is expanding rapidly in 2025.

As of July 2025, recent developments include:

  • Multidistrict Litigation (MDL) Established: In February 2024, the Judicial Panel on Multidistrict Litigation created MDL No. 3094 in the Eastern District of Pennsylvania to consolidate lawsuits involving Ozempic and related drugs. The number of cases has since grown significantly, with more than 1,800 active claims and additional filings expected throughout 2025.
  • Core Allegations: Plaintiffs allege that the manufacturers — Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro) — failed to properly disclose the risks of serious gastrointestinal injuries, including:
    • Gastroparesis (paralyzed stomach)
    • Persistent vomiting and nausea
    • Bowel obstruction or intestinal blockage
    • Severe abdominal pain and malnutrition
  • Bellwether Case Selection Underway: The MDL court is in the early stages of selecting bellwether cases, which will be used as representative trials to help gauge potential settlement value and shape the future of the litigation.
  • FDA Monitoring Ongoing: Although no recall has been issued, the FDA has acknowledged the growing number of adverse event reports and is monitoring the situation closely. In late 2024, the agency updated the labels of several GLP-1 drugs to include warnings about ileus (intestinal blockage), which further fueled new filings.

As these blockbuster drugs continue to dominate the weight loss market, the number of affected patients pursuing legal claims is expected to rise. Those experiencing unexpected and serious gastrointestinal complications after taking these medications may still be eligible to file a lawsuit.

At Riddle & Riddle Injury Lawyers, we continue to actively monitor developments in this fast-moving litigation, and we're ready to help you however we can. Please call 1-855-924-5476 for a FREE case review.

Do You Qualify for a GLP-1 Drug Lawsuit?

You may be eligible to file a lawsuit in North Carolina if:

  • You or a loved one used any of the following GLP-1 receptor agonist medications:
    • Semaglutide: Ozempic, Wegovy, Rybelsus
    • Tirzepatide: Mounjaro
    • Liraglutide: Victoza, Saxenda
    • Dulaglutide: Trulicity
    • Exenatide: Byetta, Bydureon BCise
    • Lixisenatide: Adlyxin
  • Subsequently developed serious health issues, such as:
    • Severe gastrointestinal problems (e.g., gastroparesis, intestinal blockage)
    • Vision loss or significant vision changes
    • Pancreatitis
    • Kidney or gallbladder disease
  • There is a documented link between the medication use and the onset of these health issues.
  • You have medical records confirming your diagnosis.

IMPORTANT: This litigation is fast-moving and research is ongoing. Criteria for qualifying for these lawsuits is constantly changing, so please call 1-800-525-7111 today to have your claim evaluated.

Why Choose Riddle & Riddle?

As a North Carolina-based law firm, Riddle & Riddle has a longstanding commitment to serving the residents of our state. Our deep ties to North Carolina provide us with a unique understanding of the local legal landscape and the specific needs of our clients. Here's why North Carolinians trust us:

  • Local Expertise: Our attorneys are well-versed in North Carolina laws and have established relationships within the local legal community.
  • Personalized Attention: We treat our clients like family, ensuring that you receive the individualized care and attention your case deserves.
  • Proven Track Record: Our firm has successfully recovered millions in compensation for clients in product liability and personal injury cases, including $850,000,000+ recovered since 2000 alone (see disclaimer below).

In 2025, attorney and managing partner Gene Riddle and his daughter, attorney and partner Alex Riddle, were honored when our firm was named a “Best Family-Run Law Firm” in North Carolina. 

“They really fought for what we deserved.” — Charmaine B., Riddle & Riddle client

Recognitions and Awards

Our dedication to excellence is reflected in the membership and accolades we've received (see disclaimer below):

  • Million Dollar Advocates Forum and Multi-Million Dollar Advocates Forum
  • The National Trial Lawyers Top 100
  • National Association of Distinguished Counsel
  • Super Lawyers and Super Lawyers Rising Stars
  • AV Preeminent Rating from Martindale-Hubbell

Call us today at 1-800-525-7111 for a FREE consultation.

Steps to Take If You Believe You Qualify

  1. Consult with Our Attorneys:
    • Contact Riddle & Riddle at 1-800-525-7111 for a free case evaluation.
    • Discuss your medical history and any adverse effects experienced after medication use.
  2. Gather Documentation:
    • Medical records confirming your diagnosis and detailing your health issues.
    • Records of your GLP-1 medication usage (prescriptions, dosage information).
  3. Take Legal Action:
    • If eligible and you decide to hire us, our attorneys can guide you through filing a lawsuit in North Carolina.
    • We operate on a contingency fee basis, meaning you pay nothing unless we recover compensation for you.

For a FREE case review, call our North Carolina weight loss drug and diabetes drug lawsuit attorneys at 1-800-525-7111 today.

If you qualify for a lawsuit and decide to hire us to represent you, our North Carolina legal team will guide you through the following steps:

  1. Case Evaluation: A free consultation to assess your eligibility and answer any questions.
  2. Investigation and Documentation: Collecting necessary medical records, medication history, and other pertinent evidence to build a strong case.
  3. Filing the Lawsuit: Initiating legal proceedings against the potentially liable pharmaceutical company.
  4. Negotiation and Settlement Talks: Engaging in discussions to seek a fair settlement that compensates you for your injuries and losses. Remember, however, there are no guarantees and the outcome of any case depends on the unique facts and circumstances of that case.
  5. Trial, If Necessary: If a fair settlement cannot be reached, our attorneys are prepared to help take your case to court to fight for maximum compensation.

Act Now to Protect Your Rights

$850+ million recovered since 2000 alone. Riddle & Riddle Injury Lawyers - When Justice Counts.

Lawsuits involving medications like Ozempic, Mounjaro, and other GLP-1 receptor agonists are subject to statutes of limitations, which vary by state. Delaying action can impact your ability to receive compensation. If you or a loved one has been adversely affected by these weight loss and diabetes drugs, it's crucial to seek legal counsel promptly.

Call 1-800-525-7111 today for a FREE, no-obligation consultation.

When Justice Counts™ for North Carolinians, trust the team at Riddle & Riddle Injury Lawyers. We’re ready to help however we can. Call 1-800-525-7111 for a free case review.